Alison M Elliott, Meta Roestenberg, Anne Wajja, Christopher Opio, Francis Angumya, Moses Adriko, Moses Egesa, Serah Gitome, Joseph Mfutso-Bengo, Philip Bejon, Melissa Kapulu, Zoe Seager, Tom Lutalo, Winfred Badanga Nazziwa, Asuman Muwumuza, Maria Yazdanbakhsh, Pontiano Kaleebu, Narcis Kabatereine, Edridah Tukahebwa
Controlled human infection (CHI) models are gaining recognition as an approach to accelerating vaccine development, for use in both non-endemic and endemic populations: they can facilitate identification of the most promising candidate vaccines for further trials and advance understanding of protective immunity. Helminths present a continuing health burden in sub-Saharan Africa. Vaccine development for these complex organisms is particularly challenging, partly because protective responses are akin to mechanisms of allergy...
April 18, 2018: AAS open research